NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cetera Advisors LLC | 12,700 | $7,564 | 0.00% |
| CWM, LLC | 250 | $0 | 0.00% |
| Covestor Ltd | 77 | $0 | 0.00% |
| PROVENCE WEALTH MANAGEMENT GROUP | 350 | $208 | 0.00% |
| Strategic Investment Solutions, Inc. /IL | 12,600 | $8,085 | 0.00% |
| JPMORGAN CHASE & CO | 36,741 | $21,883 | 0.00% |
| Compass Wealth Management LLC | 2,000 | $1,192 | 0.00% |
| Envestnet Portfolio Solutions, Inc. | 39,626 | $23,601 | 0.00% |
| PFS Partners, LLC | 597 | $356 | 0.00% |
| BARCLAYS PLC | 229,841 | $137 | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC | 12,702 | $8 | 0.00% |
| ROYAL BANK OF CANADA | 100 | $0 | 0.00% |
| VANGUARD GROUP INC | 12,061,147 | $7,183,619 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 20,475 | $12,195 | 0.00% |
| FEDERATED HERMES, INC. | 1,676 | $998 | 0.00% |
| JANE STREET GROUP, LLC | 21,167 | $12,607 | 0.00% |
| Cubist Systematic Strategies, LLC | 6,475 | $3,857 | 0.00% |
| UBS Group AG | 48,897 | $29,142 | 0.00% |
| EARNEST PARTNERS LLC | 83 | $49 | 0.00% |
| RHUMBLINE ADVISERS | 5,324 | $3,172 | 0.00% |
External links
This page lists NEKTAR THERAPEUTICS's shareholders in Q3 2023. To view NEKTAR THERAPEUTICS's shareholder history, click here.